What is the evidence-based approach to diagnosing and treating a patient with suspected hepatic encephalopathy and a history of liver disease?

Evidence-Based Diagnosis of Hepatic Encephalopathy

Immediate Diagnostic Approach

Hepatic encephalopathy remains a diagnosis of exclusion requiring systematic evaluation to rule out alternative causes of altered mental status, combined with clinical assessment using standardized grading scales and selective laboratory/imaging studies. 1, 2

The diagnostic workup must proceed along four parallel tracks: clinical grading, exclusion of mimics, identification of precipitants, and confirmatory testing 3, 2.

Clinical Assessment and Grading

For Overt Hepatic Encephalopathy (Grades 2-4)

• Use the West Haven Criteria as the primary grading tool when temporal disorientation is present (disorientation to day, week, month, season, or year indicates at least Grade 2) 1, 4.
• Key clinical signs with good inter-rater reliability include disorientation and asterixis—these are the marker symptoms of overt HE 5.
• Add the Glasgow Coma Scale for patients with Grade 3-4 encephalopathy or significantly altered consciousness to provide objective, reproducible assessment 1, 3.

For Covert/Minimal Hepatic Encephalopathy (Grade 0-1)

• Clinical examination alone is insufficient—specialized testing is required 5, 2.
• The Animal Naming Test serves as a simple bedside screening tool: ask patients to name as many animals as possible in 60 seconds; fewer than 20 animals suggests covert HE 2.
• For definitive diagnosis, use at least two validated testing strategies: paper-pencil tests (Psychometric Hepatic Encephalopathy Score) plus either computerized tests (Critical Flicker Frequency) or neurophysiological tests (EEG) 5, 2.
• The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) or PSE-Syndrom-Test are validated comprehensive batteries measuring multiple cognitive domains 2.

Laboratory Testing

Ammonia Measurement

• Obtain a venous or arterial ammonia level with proper collection technique in all patients with suspected HE 1, 3.
• A normal ammonia level essentially excludes hepatic encephalopathy and mandates immediate reevaluation for alternative diagnoses 1, 5, 2.
• Elevated ammonia alone does not confirm HE diagnosis—it must be interpreted in clinical context 5, 2.

Critical collection technique to avoid false results 2:

• Patient should be fasting
• Avoid venous stasis during blood draw
• Collect in EDTA tube
• Place immediately on ice
• Process rapidly

Additional Laboratory Studies

Obtain the following to exclude alternative causes and identify precipitants 2:

• Complete blood count (infection, bleeding)
• Comprehensive metabolic panel including glucose, electrolytes, calcium, renal function
• Inflammatory markers (infection)
• Coagulation studies (bleeding risk)

Brain Imaging

• Perform CT or MRI during the first episode of altered mental status to exclude intracranial hemorrhage, stroke, or structural lesions 1, 3, 2.
• Cirrhotic patients have at least 5-fold increased risk of intracerebral hemorrhage, making imaging essential 5, 2.
• Brain imaging is also indicated for seizures, focal neurological signs, or failure to respond to treatment 1, 6.
• Imaging does not confirm HE diagnosis or contribute to grading—it serves only to exclude mimics 5, 2.

Systematic Exclusion of Alternative Diagnoses

The following conditions must be actively excluded 5, 4, 2:

Metabolic/Endocrine Causes

• Hypoglycemia, diabetic ketoacidosis, hyperosmolar state 5, 4
• Hyponatremia and hypercalcemia 5, 4
• Uremic encephalopathy (may overlap with HE in end-stage liver disease) 5

Toxic/Medication-Induced

• Alcohol intoxication, withdrawal, or Wernicke encephalopathy 5, 4
• Benzodiazepines, neuroleptics, opioids 5, 4

Neurological Causes

• Intracranial hemorrhage or stroke 5, 4
• Nonconvulsive status epilepticus 5, 4
• Neuroinfections (meningitis, encephalitis) 5, 4

Other Considerations

• Sepsis (can both mimic and precipitate HE) 5
• Primary psychiatric disorders 5, 4
• Neurodegenerative diseases in chronic presentations 2

Identification of Precipitating Factors

Precipitating factors can be identified in nearly all episodes of HE and must be actively sought 4, 3:

• Infections (spontaneous bacterial peritonitis, urinary tract infection, pneumonia) 3
• Gastrointestinal bleeding 3
• Constipation 3
• Dehydration and electrolyte disorders (especially hypokalemia) 3, 6
• Medications (sedatives, diuretics) 3
• Renal dysfunction 6

Classification for Complete Diagnosis

Every case must be classified according to four factors 5, 4:

1. Type of underlying disease: Type A (acute liver failure), Type B (portosystemic bypass without liver disease), Type C (cirrhosis)
2. Severity: Covert (minimal/Grade 1) vs. Overt (Grade 2-4)
3. Time course: Episodic, recurrent (>2 bouts within 6 months), or persistent
4. Precipitating factors: Present or absent (specify if present)

Common Diagnostic Pitfalls

• Grade 1 HE is easily missed on routine clinical examination—slight psychomotor slowing and inattention require specific testing 5.
• Ammonia levels must be collected properly or results are unreliable—improper technique leads to falsely elevated values 2.
• Brain imaging is not diagnostic of HE—do not expect imaging findings to confirm the diagnosis 5, 2.
• Multiple conditions can coexist—sepsis and hyponatremia can both produce encephalopathy independently and precipitate HE simultaneously 5.
• Covert HE significantly impacts quality of life and predicts overt episodes—consider screening high-risk patients even without obvious symptoms 2.